Clinical Trial Update: Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating a combination of gemcitabine hydrochloride, paclitaxel albumin-stabilized nanoparticle formulation, metformin hydroc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)
• metformin (metformin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING